a:head bio
Vienna
About a:head bio
a:head provides a unique approach to drug development services. They develop new therapeutics for the treatment of brain disorders based on human cerebral organoids. Their drug discovery approach is based on human cerebral organoids, a revolutionary, paradigm-shifting new technology that allows the generation of mini-brains from human stem cells in vitro.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $4.5M
- Funding stage: Seed
- Last round: Seed (Oct 2024)
- Website: aheadbio.com
Industries & Categories
Biotechnology
Social Profiles
Canonical: https://fsome.com/organization/a-head-bio-109756 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.